A Narrative Review on the Management of Severe COVID-19 Infection Using Stem Cell-Based Therapies with a Focus on the Registered Clinical Trials
February 2024
TLDR Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.
The narrative review discusses the management of severe COVID-19 infections using stem cell-based therapies, with a focus on registered clinical trials. It highlights the potential use of mesenchymal stem cells (MSCs), particularly adipose-derived MSCs (AD-MSCs), not only in treating COVID-19 but also in addressing related conditions such as hair loss and telogen effluvium linked to the virus. The review suggests that the section on MSCs in COVID-19 could be enhanced by incorporating recent articles and further analysis of these therapies' potential benefits. The authors are encouraged to consider additional references to strengthen their discussion.